Journal for ImmunoTherapy of Cancer (Nov 2023)
622 Immune phenotype and iFRET functional analysis are biomarkers of response to neoadjuvant intralesional therapy for high risk stage II melanoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)